Douglas Manion

Douglas Manion

Former Chief Executive Officer and PresidentatAclaris Therapeutics· In proxies 2022–2024

Pay in FY2024-88% from the year before · Aclaris Therapeutics stock +136.2% the same year

Douglas Manion was paid $856.1K in FY2024 (Dec), down 88%. Aclaris Therapeutics stock rose 136.2% that year.

Pay$100 in the stock at the end of FY21 → $17
Pay is from the Summary Compensation Table of each Aclaris Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aclaris TherapeuticsPublic company · 4 yr
    • Former Chief Executive Officer and President2022 – Present · 4 yrStock in role -74%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?